Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(10 sites)
United States
Banner Health- MD Anderson Cancer Center, Gilbert, Arizona University of Colorado - Aurora Cancer Center, Aurora, Colorado Georgetown University Lombardi Cancer Center, Washington D.C., District of Columbia Dana-Farber Cancer Institute, Boston, Massachusetts South Texas Accelerated Research Therapeutics (START) Midwest, Grand Rapids, Michigan Masonic Cancer Center University of Minnesota, Minneapolis, Minnesota Washington University, St Louis, Missouri Memorial Sloan Kettering Cancer Center, New York, New York NEXT Virginia, Fairfax, Virginia Fred Hutchinson Cancer Research Center, Seattle, Washington